Skip to main content

Risk for Cancer Increased for Relatives of Patients With Leukemia

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 19, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Jan. 18, 2024 -- Relatives of patients with myelodysplastic neoplasia (MDS), acute myeloid leukemia (AML), or acute lymphoblastic leukemia (ALL) have an increased risk for cancer, according to a study published in the February issue of Cancer Epidemiology.

Nikolaj Juul Nitschke, from Copenhagen University Hospital in Denmark, and colleagues estimated the relative risk for cancer among relatives of patients with MDS/AML/ALL using linked data from the Danish Civil Registration System and the Danish Cancer Registry, the Danish National Acute Leukemia Registry, and the Danish Myelodysplastic Syndrome Database. Standardized incidence ratios (SIRs) were calculated as a measure of relative risk.

A total of 13,010 first-degree relatives (FDRs) and 22,051 second-degree relatives (SDRs) of 8,386 patients with MDS/AML/ALL were identified. The researchers found that the relative risk for cancer overall, excluding basal cell carcinoma (BCC), was increased among FDRs and SDRs (SIRs, 1.3 and 1.5), respectively. Among FDRs, SIRs were significantly increased for malignant melanoma, BCC, and the combined group of cancers of the male genital organs, urinary tract, and MDS/AML/ALL. SIRs were significantly increased for malignant melanoma, BCC, and cancers in the digestive organs and peritoneum among SDRs.

"We speculate that to some extent the increased cancer risk reflects polygenic cancer predisposition possibly interacting with environmental factors," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Symptom Burden Prevalent in Childhood Cancer Survivors

THURSDAY, May 9, 2024 -- Symptom burden is prevalent among young childhood cancer survivors, with caregiver anxiety and greater neighborhood deprivation associated with greater...

Most Socially Vulnerable Counties Less Likely to Have Cancer Trials

TUESDAY, May 7, 2024 -- The most socially vulnerable counties are less likely to have any cancer clinical trial, according to a research letter published online May 7 in JAMA...

Mortality Risk Up for Cancer Survivors With Elevated Loneliness

MONDAY, May 6, 2024 -- Cancer survivors with elevated loneliness have a higher mortality risk, according to a study published online April 25 in the Journal of the National...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.